期刊文献+

超声心动图在慢性肾脏病患者心血管疾病筛查中的应用价值 被引量:9

Application value of echocardiography in screening of cardiovascular disease in patients with chronic kidney disease
下载PDF
导出
摘要 目的探讨超声心动图在慢性肾脏病(CKD)患者心血管疾病筛查中的应用价值。方法选择2013年9月~2016年7月北京中医医院顺义医院(以下简称"我院")诊治的CKD患者78例作为CKD组,选择同期在我院进行体检的健康志愿者78例作为对照组,调查两组的一般资料,观察两组患者的超声心动图检查结果与肾功能常规指标检测结果,同时进行相关性分析。结果两组性别、年龄、收缩压、舒张压、体重指数等差异无统计学意义(P>0.05)。CKD组的左房内径(LAD)、左室舒张末期内径(LVDd)、左室收缩末期内径(LVDs)、左室收缩末容积(LVESV)、左室舒张末容积(LVEDV)、舒张早期跨二尖瓣血流速度/舒张晚期跨二尖瓣血流速度(E/A)值分别为(37.11±2.19)cm、(5.11±0.44)cm、(3.69±0.83)cm、(49.20±11.49)mL、(108.33±22.19)mL和(1.02±0.32),对照组分别为(34.11±3.10)cm、(4.72±0.44)cm、(2.93±0.44)cm、(25.02±5.66)mL和(76.20±13.10)mL和(1.27±0.44),两组比较差异有统计学意义(P<0.05)。CKD组的尿素氮(BUN)、肌酐(Cr)值明显高于对照组,差异有统计学意义(P<0.05),两组的血红蛋白(Hb)、尿酸(UA)、低密度脂蛋白-胆固醇(LDL-C)、三酰甘油(TG)值差异无统计学意义(P>0.05)。在CKD组中,Pearson相关分析显示:LAD、LVDd、LVDs、LVESV、LVEDV与Cr呈正相关(r=0.334、0.514、0.442、0.298、0.332,P<0.05),与E/A呈负相关(r=-0.345,P<0.05),LAD、LVDd与BUN呈正相关(r=0.442、0.301,P<0.05)。多因素回归分析显示LAD、LVDd、LVDs、E/A为影响Cr的主要独立危险因素(P<0.05),LAD、LVDd为影响BUN的主要独立危险因素(P<0.05)。结论超声心动图在CKD患者心血管疾病筛查中的应用能有效反映患者的心功能状态与病情,与肾功能常规指标密切相关。 Objective To investigate the value of echocardiography in screening of cardiovascular disease in patients with chronic kidney disease (CKD). Methods From September 2013 to July 2016, in Shunyi Hospital of Beijing Chinese Medicine Hospital ("our hospital" for short), 78 CKD patients were selected as the CKD group, and 78 healthy volunteers in our hospital were selected as the control group at the same period, the general survey data, echocardiography imaging and renal function index were recorded and given correlation analysis. Results There were no statistically significant differences in gender, age, systolic blood pressure, diastolic blood pressure, body mass index between the two groups (P 〉 0.05). The LAD, LVDd, LVDs, LVESV, LVEDV, E/A in the CKD group were (37.11±2.19) cm, (5.11± 0.44) cm, (3.69±0.83) cm, (49.20±11.49) mL, (108.33±22.19) mL and (1.02±0.32), thoes in the control group were (34.11±3.10) era, (4.72±0.44) cm, (2.93±0.44) cm, (25.02±5.66) mL and (76.20±13.10) mL and (1.27±0.44), there were statistically significant differences between the two groups in this index (P 〈 0.05). The Cr and BUN values of the CKD group were significantly higher than those of the control group, the differences were statistically significant (P 〈 0.05). There were no significant differences in UA, Hb, TG and LDL-C between the two groups (P 〉 0.05). In the CKD group, Pearson coefficient correlation analysis showed that LAD, LVDd, LVDs, LVESV, LVEDV were significantly positively correlated with Cr (r = 0.334, 0.514, 0.442, 0.298, 0.332, P 〈 0.05), E/A was negatively correlated with Cr (r = -0.345,P 〈 0.05), LAD, LVDd were positively correlation to BUN (r = 0.442, 0.301, P 〈 0.05). Multivariate regression analysis showed that LAD, LVDd, LVDs, E/A were the main independent risk factors for Cr (P 〈 0.05), LAD and INDd were the main independent risk factors for BUN (P 〈 0.05). Conclusion The application of echocardiography in the screening of cardiovascular disease in patients with chronic kidney disease can effectively reflect the state of the heart function and the condition of the patients, and it is closely related to the routine indexes of renal function.
作者 董鑫 李仁武 纪利梅 DONG Xin LI Renwu JI Limei(Department of Uhrasonography, Shunyi Hospital of Beijing Chinese Medicine Hospital, Beijing 101300, China Department of Nephrology, Shunyi Hospital of Beijing Chinese Medicine Hospital, Beijing 101300, China)
出处 《中国医药导报》 CAS 2017年第28期121-124,132,共5页 China Medical Herald
基金 北京市顺义区科技三项费项目(SYKW201603)
关键词 超声心动图 慢性肾脏病 心血管疾病 相关性 Echocardiography Chronic kidney disease Cardiovascular disease Conelation
  • 相关文献

参考文献9

二级参考文献100

  • 1侯光友,李冰,徐华丽,李少珊.BNP/NT-proBNP在心力衰竭诊断治疗中的应用进展[J].实用医药杂志,2013,30(12):1123-1125. 被引量:13
  • 2苏定冯.血压变异性与高血压的治疗[J].中华心血管病杂志,2005,33(9):863-865. 被引量:109
  • 3SantangeliP,MarchlinskiFE.Effectiveness of antitachycardia pacing for recurrent ventricular tachycardia in ARVC[J].J Am Coll Cardiol,2014,64:2558-2560.
  • 4Steinberg BA, Zhao X, Heidenreich PA, et al. Get With the Guide- lines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction : prevalence, therapies, and outcomes[ J ]. Circulation, 2019, 126(1): 65-75.
  • 5Marttnez-Sell6s M, Doughty RN, Poppe K, et al. Meta-Analysis Global Group In Chronic Heart Failure (MAGGIC). Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis [J]. Eur J Heart Fail, 2012, 14(5): 473-479.
  • 6Lam CS, Carson PE, Anand IS, et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial [ J ]. Circ Heart Fail, 2012, 5(5) : 571 -578.
  • 7O'Meara E, Clayton T, MeEntegart MB, et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity ( CHARM ) program [ J ]. Circulation, 2007, 115 (24) : 3111 - 3120.
  • 8Alia F, A1-Hindi AY, Lee CR, et al. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction[ J]. Am Heart J, 2007, 153 (6) : 1074 - 1080.
  • 9Deswal A, Bozkurt B. Cmnparison of morbidity in women versus men with heart failure and preserved ejection fraction [ J ]. Am J Cardiol, 2006, 97(8): 1228- 1231.
  • 10Brandsaeter B, Atar D, Agewall S, et al. Gender differences among Norwegian patients with heart failure[ J]. Int J Cardiol, 20l 1, 146 (3): 354-358.

共引文献93

同被引文献64

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部